13F Holdings
中文EN

DMII Drugs Made In America Acquisition II Corp.

Blank Checks · Nasdaq · SEC CIK 2040475 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA3.5%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets3.5%
Debt / equity—
Current ratio0.22x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.04x
Accruals ratio3.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-31
Income statement
Revenue———————
SG&A expense$77,010$112,227$132,030$235,472$155,513$38,073$59,327
Operating income-$77,010-$112,227-$132,030-$235,472-$155,513-$38,073-$59,327
Net income$4.62M$4.40M$4.34M$4.33M-$46,158-$38,073-$59,327
EPS (diluted)———————
Balance sheet
Cash & equivalents$118,232$174,974$347,720$223$315,087$4,394$6,991
Current assets$139,657$217,823$351,761$26,037$896,356——
Total assets$518.72M$514.10M$509.73M$504.96M$501.01M——
Current liabilities$643,418$644,574$666,285$300,864$677,345——
Short-term debt—$450,000$450,000————
Total liabilities$18.14M$18.14M$18.17M$17.80M$18.18M——
Shareholders' equity-$18.00M-$17.93M-$17.81M-$17.77M-$17.28M-$214,119-$176,046
Shares outstanding13.70M13.70M13.70M13.70M15.57M——
Cash flow statement
Operating cash flow-$56,742-$172,746-$102,503-$314,864-$690,726-$2,597-$10,044
Investing cash flow———$0———
Financing cash flow$0$0$450,000$0———

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.